A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?
Philip O. Katz(Cornell University), Péter Nagy(AstraZeneca (Sweden)), Kerstin Röhss(AstraZeneca (Sweden)), Deborah Levine(Beth Israel Deaconess Medical Center), David A. Johnson(University of Chicago), Ola Junghard(AstraZeneca (Sweden)), Magnus Åstrand(AstraZeneca (Sweden))
Cited by 14
Related Papers
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
|Circulation|2008|845
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole
|Gastroenterology|2001|614
Nocturnal Recovery of Gastric Acid Secretion With Twice-Daily Dosing of Proton Pump Inhibitors
|The American Journal of Gastroenterology|1998|319